Business Context and Reporting Period
This Form 8-K is a current report filed by Aikido Pharma Inc. (not Dominari Holdings Inc.) on March 30, 2022. The filing addresses Item 8.01 (Other Events) regarding the scheduling of the company's 2022 Annual Meeting of Shareholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is administrative in nature and contains no financial performance data.
Material Changes
The primary material change reported is the confirmation of the date for the 2022 Annual Meeting of Shareholders, which has been set for Monday, May 16, 2022. This date represents a change of more than 30 days from the anniversary of the previous annual meeting.
Guidance, Outlook, and Management Commentary
- Shareholder Proposals: Due to the date change, the deadline for shareholders to submit nominations for directors or other business proposals has been updated.
- Submission Deadline: Shareholders must ensure proper notice is received by the Company no later than April 6, 2022.
- Requirements: Notices must include all information required by the Company's By-laws.
- Future Filings: Specific details regarding the time, location, and matters to be considered will be included in the definitive proxy statement to be filed with the SEC in due course.
Important Facts for Investors to Verify
- Verify the exact time and physical/virtual location of the Annual Meeting once the definitive proxy statement is filed.
- Confirm the April 6, 2022 deadline if intending to submit director nominations or shareholder proposals.
- Review the Company's By-laws to ensure any submitted notices meet all specific informational requirements.